Contrast-induced nephropathy

Critical Care Clinics

Volumn 21, Issue 2, 2005, Pages 261-280

  McCullough, Peter A ^a   Soman, Sandeep S ^b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b Fargo VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE; AMINOPHYLLINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ASCORBIC ACID; BICARBONATE; CONTRAST MEDIUM; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; FENOLDOPAM; HEPARIN; INFUSION FLUID; IODIXANOL; IOHEXOL; LOOP DIURETIC AGENT; MANNITOL; MEGLUMINE DIATRIZOATE PLUS SODIUM DIATRIZOATE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; SODIUM CHLORIDE; THEOPHYLLINE;

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTRAST INDUCED KIDNEY DISEASE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DRUG INDUCED DISEASE; DRUG POTENTIATION; FLUID THERAPY; GLOMERULUS FILTRATION RATE; HEMOFILTRATION; HIGH RISK POPULATION; HUMAN; HYDRATION; HYPERTENSION; HYPOVOLEMIA; KIDNEY DISEASE; KIDNEY FUNCTION; LACTIC ACIDOSIS; LONG TERM CARE; MORTALITY; NEPHROTOXICITY; OBESITY; OSMOLALITY; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; RENAL PROTECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; URINE FLOW RATE;

EID: 15244341062     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2004.12.003     Document Type: Review

References (87)

1. D.B. Cotton Radiocontrast-induced renal failure Lancet 2 8156-8157 1979 1378 1379
2. Radiocontrast-induced renal failure Lancet 2 8147 1979 835
3. R. Solomon, C. Werner, and D. Mann Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents N Engl J Med 331 21 1994 1416 1420
4. K. Nash, A. Hafeez, and S. Hou Hospital-acquired renal insufficiency Am J Kidney Dis 39 5 2002 930 936
5. A.J. Taylor, D. Hotchkiss, and R.W. Morse PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs. outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction Chest 114 6 1998 1570 1574
6. P.A. McCullough, and K.R. Sandberg Epidemiology of contrast-induced nephropathy Rev Cardiovasc Med 4 Suppl 5 2003 S3 S9
7. L. Gruberg, R. Mehran, and G. Dangas Acute renal failure requiring dialysis after percutaneous coronary interventions Catheter Cardiovasc Interv 52 2001 409 416
8. C.E. Lewis, D. Jacobs Jr, and H. McCreath Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA study. Coronary Artery Risk Development in Young Adults Am J Epidemiol 151 12 2000 1172 1181
9. G.L. Bakris, M. Williams, and L. Dworkin Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group Am J Kidney Dis 36 3 2000 646 661
10. P.A. McCullough, R. Wolyn, and I.I. Rocher Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality Am J Med 103 5 1997 368 375
11. C.M. Mangano, L.S. Diamondstone, and J.G. Ramsay Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group Ann Intern Med 128 3 1998 194 203
12. C.S. Rihal, S.C. Textor, and D.E. Grill Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention Circulation 105 19 2002 2259 2264
13. P.A. McCullough Cardiorenal risk: an important clinical intersection Rev Cardiovasc Med 3 2 2002 71 76
14. R.E. Katholi, G.J. Taylor, and W.P. McCann Nephrotoxicity from contrast media: attenuation with theophylline Radiology 195 1 1995 17 22
15. B.J. Barrett Contrast nephrotoxicity J Am Soc Nephrol 5 2 1994 125 137
16. S.K. Morcos Prevention of contrast media nephrotoxicity-the story so far Clin Radiol 59 5 2004 381 389
17. C.S. McCarthy, and J.A. Becker Multiple myeloma and contrast media Radiology 183 2 1992 519 521
18. P.S. Parfrey, S.M. Griffiths, and B.J. Barrett Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study N Engl J Med 320 3 1989 143 149
19. M.R. Rudnick, S. Goldfarb, and L. Wexler Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study Kidney Int 47 1 1995 254 261
20. B.J. Barrett, P.S. Parfrey, and H.M. Vavasour Contrast nephropathy in patients with impaired renal function: high versus low osmolar media Kidney Int 41 5 1992 1274 1279
21. A.S. Abizaid, C.E. Clark, and G.S. Mintz Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency Am J Cardiol 83 2 1999 260 263
22. E.M. Levy, C.M. Viscoli, and R.I. Horwitz The effect of acute renal failure on mortality. A cohort analysis JAMA 275 19 1996 1489 1494
23. H.S. Thomsen, and S.K. Morcos Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee Eur Radiol 9 4 1999 738 740
24. L.S. Fang, R.A. Sirota, and T.H. Ebert Low fractional excretion of sodium with contrast media-induced acute renal failure Arch Intern Med 140 4 1980 531 533
25. M.L. Gelman, and C.H. Coggins Effects of an angiographic contrast agent on renal function Cardiovasc Med 4 1979 313
26. L.A. Weinrauch, R.W. Healy, and O.S. Leland Coronary angiography and acute renal failure in diabetic azotemic nephropathy Ann Intern Med 86 1 1977 56 59
27. J.A. D'Elia, R.E. Gleason, and M. Alday Nephrotoxicity from angiographic contrast material. A prospective study Am J Med 72 5 1982 719 725
28. K. Margulies, J. Schirger, and J. Burnett Jr Radiocontrast-induced nephropathy: current status and future prospects Int Angiol 11 1 1992 20 25
29. K.J. Andersen, E.I. Christensen, and H. Vik Effects of iodinated x-ray contrast media on renal epithelial cells in culture Invest Radiol 29 11 1994 955 962
30. E.C. Keeley, and C.L. Grines Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases J Am Coll Cardiol 32 7 1998 1861 1865
31. K.M. Denton, A. Shweta, and W.P. Anderson Preglomerular and postglomerular resistance responses to different levels of sympathetic activation by hypoxia J Am Soc Nephrol 13 1 2002 27 34
32. M. Brezis, and S. Rosen Hypoxia of the renal medulla-its implications for disease N Engl J Med 332 10 1995 647 655
33. M. Uder, U. Humke, and M. Pahl Nonionic contrast media iohexol and iomeprol decrease renal arterial tone: comparative studies on human and porcine isolated vascular segments Invest Radiol 37 8 2002 440 447
34. D. Rauch, P. Drescher, and F.J. Pereira Comparison of iodinated contrast media-induced renal vasoconstriction in human, rabbit, dog, and pig arteries Invest Radiol 32 6 1997 315 319
35. Y. Fukumoto, H. Tsutsui, and M. Tsuchihashi The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study J Am Coll Cardiol 42 2 2003 211 216
36. F. Scolari, M. Bracchi, and B. Valzorio Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure Nephrol Dial Transplant 11 8 1996 1607 1612
37. S.J. Rosansky, and E.G. Deschamps Multiple cholesterol emboli syndrome after angiography Am J Med Sci 288 1 1984 45 48
38. G. Ramirez, W.M. O'Neill Jr, and R. Lambert Cholesterol embolization: a complication of angiography Arch Intern Med 138 9 1978 1430 1432
39. F. Scolari, R. Tardanico, and R. Zani Cholesterol crystal embolism: a recognizable cause of renal disease Am J Kidney Dis 36 6 2000 1089 1109
40. M.R. Rudnick, J.S. Berns, and R.M. Cohen Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism-a critical review Am J Kidney Dis 24 4 1994 713 727
41. J.P. Kassirer Atheroembolic renal disease N Engl J Med 280 15 1969 812 818
42. M.J. Fine, W. Kapoor, and V. Falanga Cholesterol crystal embolization: a review of 221 cases in the English literature Angiology 38 10 1987 769 784
43. S. Saleem, F.G. Lakkis, and M. Martinez-Maldonado Atheroembolic renal disease Semin Nephrol 16 4 1996 309 318
44. P.J. Dahlberg, D.F. Frecentese, and T.H. Cogbill Cholesterol embolism: experience with 22 histologically proven cases Surgery 105 6 1989 737 746
45. B. Pitt, R. Segal, and F.A. Martinez Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Lancet 349 9054 1997 747 752
46. R. Toto Angiotensin II subtype 1 receptor blockers and renal function Arch Intern Med 161 12 2001 1492 1499
47. E.J. Lewis, L.G. Hunsicker, and W.R. Clarke Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 12 2001 851 860
48. H.H. Parving, H. Lehnert, and J. Brochner-Mortensen The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N Engl J Med 345 12 2001 870 878
49. B. Dahlof, R.B. Devereux, and S.E. Kjeldsen Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 9311 2002 995 1003
50. B.M. Brenner, M.E. Cooper, and D. de Zeeuw Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 12 2001 861 869
51. J.F. Mann, H.C. Gerstein, and J. Pogue Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 8 2001 629 636
52. L.Y. Agodoa, L. Appel, and G.L. Bakris Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial JAMA 285 21 2001 2719 2728
53. P.A. McCullough, and H.J. Manley Prediction and prevention of contrast nephropathy J Interv Cardiol 14 5 2001 547 558
54. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 Suppl 1 2002 S1 S266
55. P.A. McCullough, S.S. Soman, and S.S. Shah Risks associated with renal dysfunction in patients in the coronary care unit J Am Coll Cardiol 36 3 2000 679 684
56. J.N. Beattie, S.S. Soman, and R. Sandberg Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction Am J Kidney Dis 37 6 2001 1191 1200
57. G.M. Chertow, J.M. Lazurus, and C.L. Christiansen Preoperative renal risk stratification Circulation 95 4 1997 878 884
58. L.A. Szczech, P. Best, and E. Crowley Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation Circulation 105 19 2002 2253 2258
59. W.F. Keane, and G. Eknoyan Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation Am J Kidney Dis 33 5 1999 1004 1010
60. R. Mehran, E.D. Aymong, and E. Nikolsky A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 7 2004 1393 1399
61. C. Mueller, G. Buerkle, and H.J. Buettner Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty Arch Intern Med 162 3 2002 329 336
62. M.A. Stevens, P.A. McCullough, and K.J. Tobin A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation J Am Coll Cardiol 33 2 1999 403 411
63. Z.A. Abassi, H. Klein, and E. Golomb Urinary endothelin: a possible biological marker of renal damage Am J Hypertens 6 12 1993 1046 1054
64. C.J. Davidson, W.K. Laskey, and J.B. Hermiller Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial Circulation 101 18 2000 2172 2177
65. C.L. Manske, J.M. Sprafka, and J.T. Strony Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography Am J Med 89 5 1990 615 620
66. G.W. Stone, J.A. Tumlin, and H. Madyoon Design and rationale of CONTRAST-a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy Rev Cardiovasc Med 2 Suppl 1 2001 S31 S36
67. M. Tepel, M. van der Giet, and C. Schwarzfeld Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 3 2000 180 184
68. A. Ochoa, G. Pellizzon, and S. Addala Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention J Interv Cardiol 17 3 2004 159 165
69. C.S. Baker, A. Wragg, and S. Kumar A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study J Am Coll Cardiol 41 12 2003 2114 2118
70. C. Briguori, A. Colombo, and A. Violante Standard vs. double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity Eur Heart J 25 3 2004 206 211
71. A.V. Kshirsagar, C. Poole, and A. Mottl N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials J Am Soc Nephrol 15 3 2004 761 769
72. A. Alonso, J. Lau, and B.L. Jaber Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials Am J Kidney Dis 43 1 2004 1 9
73. W. Huber, K. Ilgmann, and M. Page Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study Radiology 223 3 2002 772 779
74. A. Kapoor, S. Kumar, and S. Gulati The role of theophylline in contrast-induced nephropathy: a case-control study Nephrol Dial Transplant 17 11 2002 1936 1941
75. A. Kolonko, A. Wiecek, and F. Kokot The nonselective adenosine antagonist theophylline does prevent renal dysfunction induced by radiographic contrast agents J Nephrol 11 3 1998 151 156
76. C.M. Erley, S.H. Duda, and S. Schlepckow Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application Kidney Int 45 5 1994 1425 1431
77. C.M. Erley, S.H. Duda, and D. Rehfuss Prevention of radiocontrast-media- induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline Nephrol Dial Transplant 14 5 1999 1146 1149
78. W. Huber, C. Schipek, and K. Ilgmann Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency Am J Cardiol 91 10 2003 1157 1162
79. J.H. Ix, C.E. McCulloch, and G.M. Chertow Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis Nephrol Dial Transplant 19 11 2004 2747 2753
80. G. Marenzi, and A.L. Bartorelli Hemofiltration in the prevention of radiocontrast agent induced nephropathy Minerva Anestesiol 70 4 2004 189 191
81. B. Vogt, P. Ferrari, and C. Schonholzer Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful Am J Med 111 9 2001 692 698
82. L.G. Forni, and P.J. Hilton Continuous hemofiltration in the treatment of acute renal failure N Engl J Med 336 18 1997 1303 1309
83. G. Marenzi, G. Lauri, and M. Grazi Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure J Am Coll Cardiol 38 4 2001 963 968
84. G. Marenzi, A.L. Bartorelli, and G. Lauri Continuous veno-venous hemofiltration for the treatment of contrast-induced acute renal failure after percutaneous coronary interventions Catheter Cardiovasc Interv 58 1 2003 59 64
85. R. Schindler, C. Stahl, and S. Venz Removal of contrast media by different extracorporeal treatments Nephrol Dial Transplant 16 7 2001 1471 1474
86. P. Jungers, Z.A. Massy, and T.N. Khoa Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study Nephrol Dial Transplant 12 12 1997 2597 2602
87. G. Marenzi, and A.L. Bartorelli Recent advances in the prevention of radiocontrast-induced nephropathy Curr Opin Crit Care 10 2004 505 509